Literature DB >> 33275950

Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.

.   

Abstract

BACKGROUND: To contribute to the WHO initiative, VISION 2020: The Right to Sight, an assessment of global vision impairment in 2020 and temporal change is needed. We aimed to extensively update estimates of global vision loss burden, presenting estimates for 2020, temporal change over three decades between 1990-2020, and forecasts for 2050.
METHODS: We did a systematic review and meta-analysis of population-based surveys of eye disease from January, 1980, to October, 2018. Only studies with samples representative of the population and with clearly defined visual acuity testing protocols were included. We fitted hierarchical models to estimate 2020 prevalence (with 95% uncertainty intervals [UIs]) of mild vision impairment (presenting visual acuity ≥6/18 and <6/12), moderate and severe vision impairment (<6/18 to 3/60), and blindness (<3/60 or less than 10° visual field around central fixation); and vision impairment from uncorrected presbyopia (presenting near vision <N6 or <N8 at 40 cm where best-corrected distance visual acuity is ≥6/12). We forecast estimates of vision loss up to 2050.
FINDINGS: In 2020, an estimated 43·3 million (95% UI 37·6-48·4) people were blind, of whom 23·9 million (55%; 20·8-26·8) were estimated to be female. We estimated 295 million (267-325) people to have moderate and severe vision impairment, of whom 163 million (55%; 147-179) were female; 258 million (233-285) to have mild vision impairment, of whom 142 million (55%; 128-157) were female; and 510 million (371-667) to have visual impairment from uncorrected presbyopia, of whom 280 million (55%; 205-365) were female. Globally, between 1990 and 2020, among adults aged 50 years or older, age-standardised prevalence of blindness decreased by 28·5% (-29·4 to -27·7) and prevalence of mild vision impairment decreased slightly (-0·3%, -0·8 to -0·2), whereas prevalence of moderate and severe vision impairment increased slightly (2·5%, 1·9 to 3·2; insufficient data were available to calculate this statistic for vision impairment from uncorrected presbyopia). In this period, the number of people who were blind increased by 50·6% (47·8 to 53·4) and the number with moderate and severe vision impairment increased by 91·7% (87·6 to 95·8). By 2050, we predict 61·0 million (52·9 to 69·3) people will be blind, 474 million (428 to 518) will have moderate and severe vision impairment, 360 million (322 to 400) will have mild vision impairment, and 866 million (629 to 1150) will have uncorrected presbyopia.
INTERPRETATION: Age-adjusted prevalence of blindness has reduced over the past three decades, yet due to population growth, progress is not keeping pace with needs. We face enormous challenges in avoiding vision impairment as the global population grows and ages. FUNDING: Brien Holden Vision Institute, Fondation Thea, Fred Hollows Foundation, Bill & Melinda Gates Foundation, Lions Clubs International Foundation, Sightsavers International, and University of Heidelberg.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Year:  2020        PMID: 33275950     DOI: 10.1016/S2214-109X(20)30425-3

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  86 in total

1.  In vivo MRI evaluation of anterograde manganese transport along the visual pathway following whole eye transplantation.

Authors:  Chiaki Komatsu; Yolandi van der Merwe; Lin He; Anisha Kasi; Jeffrey R Sims; Maxine R Miller; Ian A Rosner; Neil J Khatter; An-Jey A Su; Joel S Schuman; Kia M Washington; Kevin C Chan
Journal:  J Neurosci Methods       Date:  2022-02-22       Impact factor: 2.390

2.  Longitudinal Associations Between Vision Impairment and the Incidence of Neuropsychiatric, Musculoskeletal, and Cardiometabolic Chronic Diseases.

Authors:  Ajay Kolli; Kristian Seiler; Neil Kamdar; Lindsey B De Lott; Mark D Peterson; Michelle A Meade; Joshua R Ehrlich
Journal:  Am J Ophthalmol       Date:  2021-09-20       Impact factor: 5.258

3.  Zinc and Copper Ions Induce Aggregation of Human β-Crystallins.

Authors:  Vanesa Ramirez-Bello; Javier Martinez-Seoane; Arline Fernández-Silva; Carlos Amero
Journal:  Molecules       Date:  2022-05-06       Impact factor: 4.927

4.  Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains.

Authors:  Preeti Gupta; Eva K Fenwick; Ryan E K Man; Alfred T L Gan; Charumathi Sabanayagam; Debra Quek; Chaoxu Qian; Chui Ming Gemmy Cheung; Ching-Yu Cheng; Ecosse L Lamoureux
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

5.  Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma.

Authors:  Marta Ibarz Barberá; Fátima Martínez-Galdón; Elena Caballero-Magro; Marta Rodríguez-Piñero; Pedro Tañá-Rivero
Journal:  J Glaucoma       Date:  2022-05-17       Impact factor: 2.290

6.  The Association of Cognitive and Visual Function in a Nationally Representative Study of Older Adults in India.

Authors:  Joshua R Ehrlich; Tochukwu Ndukwe; Sandy Chien; Jinkook Lee
Journal:  Neuroepidemiology       Date:  2021-02-24       Impact factor: 3.282

Review 7.  Advancing Diabetic Retinopathy Research: Analysis of the Neurovascular Unit in Zebrafish.

Authors:  Chiara Simone Middel; Hans-Peter Hammes; Jens Kroll
Journal:  Cells       Date:  2021-05-25       Impact factor: 6.600

8.  Midlife Vision Impairment and Cognitive Function in Later Life: The Study of Women's Health Across the Nation, Michigan Cohort.

Authors:  Ajay Kolli; Michelle M Hood; Carrie Karvonen-Gutierrez; Sayoko E Moroi; Joshua R Ehrlich; Brenda W Gillespie; Sarah Dougherty Wood; David C Musch
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-11-15       Impact factor: 6.591

9.  Association of objective and subjective far vision impairment with perceived stress among older adults in six low- and middle-income countries.

Authors:  Louis Jacob; Karel Kostev; Lee Smith; Guillermo F López-Sánchez; Shahina Pardhan; Hans Oh; Jae Il Shin; Adel S Abduljabbar; Josep Maria Haro; Ai Koyanagi
Journal:  Eye (Lond)       Date:  2021-06-18       Impact factor: 4.456

Review 10.  Foundational concepts in the biology of bacterial keratitis.

Authors:  Lawson Ung; James Chodosh
Journal:  Exp Eye Res       Date:  2021-06-05       Impact factor: 3.770

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.